{"id":"W2077037832","doi":"10.1016/j.clbc.2013.10.016","title":"Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Merck","keywords":"Medicine; Capecitabine; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001516476,0.001886725,0.003547258,0.0004686083,0.0004875189,0.001286798,0.001015351,0.001416397,0.008457474],"category_scores_gemma":[0.001944218,0.0009081569,0.001416043,0.000515894,0.001629685,0.001323525,0.0004950336,0.003928126,0.001176231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001510864,"about_ca_system_score_gemma":0.00162774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002071282,"about_ca_topic_score_gemma":0.005411176,"domain_scores_codex":[0.999443,0.0002949073,0.00002647689,0.000106076,0.00002829247,0.0001012874],"domain_scores_gemma":[0.9989443,0.0003129264,0.0001841065,0.00008773196,0.00004984193,0.0004210403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.984235,0.003738799,0.0002471939,0.0002649607,0.0003503634,0.00002166089,0.00002716786,0.0003939369,0.001369614,0.0001356147,0.0005429303,0.00867278],"study_design_scores_gemma":[0.9643609,0.03384652,0.0005256326,0.00001452785,0.0001713069,0.0000189513,0.00001624707,0.0002980266,0.0001672157,0.0001409617,0.0004319134,0.000007782311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827883,0.004852342,0.0008905178,0.001435045,0.001342519,0.003566382,0.001167857,0.0001420616,0.003814969],"genre_scores_gemma":[0.9832023,0.002969391,0.00169297,0.001542526,0.0005954786,0.003159839,0.00135162,0.00004194543,0.005443934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008457474,"threshold_uncertainty_score":0.02829307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02014164253463134,"score_gpt":0.3471441605379508,"score_spread":0.3270025180033195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}